TRPA1 and Alzheimer disease: These results suggest that increase of Th2-related cytokines and IL-31-induced TRPA1 expression are induced by STAT1 and STAT3 signaling, and cASC and cASC-EVs improve AD by suppressing STAT1 and STAT3 signaling.